Winro Commercial (India) Ltd
Winro Commercial (India) is RBI Registered Non Banking Financial Company (Non Deposit taking) engaged in the business of investment, trading in shares and securities & Lending Activities.
- Market Cap ₹ 30.6 Cr.
- Current Price ₹ 244
- High / Low ₹ /
- Stock P/E 0.10
- Book Value ₹ 23,665
- Dividend Yield 0.00 %
- ROCE 18.9 %
- ROE 17.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.01 times its book value
- Company is expected to give good quarter
- Company has delivered good profit growth of 54.9% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Contingent liabilities of Rs.15.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 | 16 | 35 | 47 | 9 | 92 | 179 | 134 | 441 | 448 | 200 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 10 | 7 | 11 | 4 |
| 1 | 3 | 3 | 2 | 61 | 2 | 4 | 5 | 8 | 11 | 10 | |
| Financing Profit | 30 | 13 | 31 | 45 | -51 | 88 | 172 | 119 | 426 | 426 | 185 |
| Financing Margin % | 96% | 82% | 90% | 95% | -543% | 95% | 96% | 88% | 97% | 95% | 93% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit before tax | 29 | 13 | 31 | 45 | -51 | 88 | 172 | 118 | 425 | 426 | 185 |
| Tax % | -7% | 18% | -20% | 7% | -34% | 35% | 14% | 21% | 16% | 20% | |
| 40 | 19 | 67 | 52 | -58 | 111 | 180 | 82 | 482 | 402 | 300 | |
| EPS in Rs | 319.20 | 151.14 | 536.13 | 411.66 | -463.79 | 887.58 | 1,434.97 | 657.72 | 3,846.23 | 3,209.26 | 2,397.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 117% |
| 3 Years: | 36% |
| TTM: | -64% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 31% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 288 | 307 | 379 | 431 | 393 | 768 | 1,139 | 1,207 | 1,938 | 2,629 | 2,963 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 194 | 94 | 30 | 20 | 20 |
| 1 | 1 | 1 | 1 | 0 | 13 | 44 | 28 | 86 | 125 | 155 | |
| Total Liabilities | 290 | 309 | 382 | 433 | 395 | 782 | 1,378 | 1,330 | 2,055 | 2,776 | 3,139 |
| 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 167 | 204 | 216 | 279 | 307 | 742 | 1,142 | 1,248 | 1,836 | 2,459 | 2,708 |
| 122 | 105 | 164 | 153 | 87 | 37 | 234 | 80 | 218 | 316 | 430 | |
| Total Assets | 290 | 309 | 382 | 433 | 395 | 782 | 1,378 | 1,330 | 2,055 | 2,776 | 3,139 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -84 | 24 | -88 | -2 | 44 | 79 | -33 | -33 | -57 | -113 | |
| 84 | -24 | 88 | 2 | -37 | -85 | -159 | 148 | 146 | 113 | |
| 0 | 0 | 0 | -0 | -0 | -2 | 192 | -110 | -70 | -21 | |
| Net Cash Flow | 0 | 0 | -0 | 1 | 7 | -8 | 0 | 5 | 19 | -21 |
| Free Cash Flow | -84 | 24 | -88 | -2 | 44 | 77 | -33 | -33 | -57 | -113 |
| CFO/OP | -274% | 195% | -274% | 6% | -86% | 98% | -14% | 3% | -0% | -11% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 14% | 6% | 20% | 13% | -14% | 19% | 19% | 7% | 31% | 18% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|
| Distinct Equity Scripts in Investment Portfolio Number ・Standalone data |
|
|||||||
| Dividend Income INR Lakhs ・Standalone data |
||||||||
| Investment Portfolio Size (Standalone) INR Lakhs ・Standalone data |
||||||||
| Number of Associate Companies Number ・Standalone data |
||||||||
| Windmill Revenue (Sale of Electricity) INR Lakhs ・Standalone data |
||||||||
| NSE Shares Held Number ・Standalone data |
||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper Publication regarding special window for transfer and dematerialisation of physcial securities of Winro Commercial (India) Limited.
- Closure of Trading Window 25 Mar
-
Disclosure Under Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations, 2015.
24 Mar - Income-tax demand Rs.3,64,97,710 for AY2022-23; company to appeal, seek stay.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
19 Mar - Converted 10,71,157 Bharti Airtel shares to fully-paid; paid Rs42.98 crore on 18-19 Mar 2026; holding 1,071,425 shares.
-
Announcement under Regulation 30 (LODR)-Acquisition
13 Mar - Pays Rs.401.25 per share for 10,71,157 Airtel shares; Rs.42.98 crore blocked ASBA on 13-Mar-2026.
Annual reports
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse